vs
Side-by-side financial comparison of AECOM (ACM) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.8B, roughly 1.4× AECOM). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 1.9%, a 6.0% gap on every dollar of revenue. On growth, AECOM posted the faster year-over-year revenue change (1.6% vs -0.3%).
AECOM is an American multinational infrastructure consulting firm headquartered in Dallas, Texas.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
ACM vs FMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.8B | $5.5B |
| Net Profit | $74.5M | $434.2M |
| Gross Margin | 7.3% | 27.4% |
| Operating Margin | 5.8% | 11.7% |
| Net Margin | 1.9% | 7.9% |
| Revenue YoY | 1.6% | -0.3% |
| Net Profit YoY | -48.0% | 240.4% |
| EPS (diluted) | $0.56 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.8B | — | ||
| Q4 25 | — | $5.5B | ||
| Q3 25 | $4.2B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $4.0B | $5.5B | ||
| Q3 24 | $4.1B | — | ||
| Q2 24 | $4.2B | — |
| Q1 26 | $74.5M | — | ||
| Q4 25 | — | $434.2M | ||
| Q3 25 | $120.4M | — | ||
| Q2 25 | $131.0M | — | ||
| Q1 25 | $143.4M | — | ||
| Q4 24 | $167.0M | $127.6M | ||
| Q3 24 | $172.5M | — | ||
| Q2 24 | $134.3M | — |
| Q1 26 | 7.3% | — | ||
| Q4 25 | — | 27.4% | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 6.7% | 25.0% | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 6.9% | — |
| Q1 26 | 5.8% | — | ||
| Q4 25 | — | 11.7% | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 5.9% | 5.1% | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 5.5% | — |
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | 7.9% | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 4.2% | 2.3% | ||
| Q3 24 | 4.2% | — | ||
| Q2 24 | 3.2% | — |
| Q1 26 | $0.56 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $0.90 | — | ||
| Q2 25 | $0.98 | — | ||
| Q1 25 | $1.08 | — | ||
| Q4 24 | $1.25 | — | ||
| Q3 24 | $1.27 | — | ||
| Q2 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $1.7B |
| Total DebtLower is stronger | $2.6B | — |
| Stockholders' EquityBook value | $2.2B | $15.4B |
| Total Assets | $11.9B | $33.5B |
| Debt / EquityLower = less leverage | 1.18× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.2B | — | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
| Q1 26 | $2.6B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | — | $15.4B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.2B | $17.0B | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.3B | — |
| Q1 26 | $11.9B | — | ||
| Q4 25 | — | $33.5B | ||
| Q3 25 | $12.2B | — | ||
| Q2 25 | $12.3B | — | ||
| Q1 25 | $11.8B | — | ||
| Q4 24 | $11.8B | $36.3B | ||
| Q3 24 | $12.1B | — | ||
| Q2 24 | $12.0B | — |
| Q1 26 | 1.18× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.06× | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.11× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.2M | $2.9B |
| Free Cash FlowOCF − Capex | $41.9M | — |
| FCF MarginFCF / Revenue | 1.1% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 0.94× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | $616.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $70.2M | — | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | $196.1M | — | ||
| Q2 25 | $283.7M | — | ||
| Q1 25 | $190.7M | — | ||
| Q4 24 | $151.1M | $2.6B | ||
| Q3 24 | $298.8M | — | ||
| Q2 24 | $291.3M | — |
| Q1 26 | $41.9M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $134.1M | — | ||
| Q2 25 | $261.7M | — | ||
| Q1 25 | $178.3M | — | ||
| Q4 24 | $110.9M | — | ||
| Q3 24 | $274.5M | — | ||
| Q2 24 | $272.8M | — |
| Q1 26 | 1.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 6.6% | — |
| Q1 26 | 0.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.4% | — |
| Q1 26 | 0.94× | — | ||
| Q4 25 | — | 6.67× | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 2.17× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 0.90× | 20.20× | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | 2.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
